Literature DB >> 31358479

The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.

Nozomu Kurose1, Xin Guo2, Akihiro Shioya2, Ken-Ichi Mizutani2, Motona Kumagai2, Shino Fujimoto3, Hiroshi Kawabata3, Yasufumi Masaki3, Kazue Takai4, Sadao Aoki5, Shigeo Nakamura6, Sohsuke Yamada2.   

Abstract

Idiopathic multicentric Castleman disease (iMCD) is a systemic inflammatory disease of unknown etiology caused by hypercytokinemia. Recently, TAFRO (thrombocytopenia, anasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome has been reported, which shows similar histopathological findings to iMCD and factors associated with a poor prognosis. iMCD shows no plasma cell infiltration in the germinal center (GC), but CD38-positive (CD38+)-plasma cells are observed in the interfollicular area. Our previous report revealed that atrophic change of GC, glomeruloid vascular proliferation, and abnormal proliferation of follicular dendritic cells are more prominent in iMCD with TAFRO (TAFRO+) in comparison to iMCD without TAFRO (TAFRO-). In addition, the numbers of CD38+ and immunoglobulin G4-positive (IgG4+) plasma cells were decreased in the interfollicular area. The roles of T follicular helper cells (Tfh) are well-known to assist B-cell proliferation, maturation, and differentiation.It maintains the formation of GC and is also related in the class switching of IgG isotypes, including IgG4. Thus, we immunohistochemically examined the number of Tfh in GCs in both TAFRO- and TAFRO+ iMCD. The number of Tfh was significantly decreased in TAFRO- iMCD (n = 9) and was further decreased in TAFRO+ iMCD (n = 18) in comparison to non-specific lymphadenopathy (n = 6) and IgG4-related disease (n = 4). These results suggest that decreased Tfh may be one etiology of iMCD.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CD40L; CXCR5; Follicular helper T cell; IgG4-related disease; TAFRO syndrome

Mesh:

Substances:

Year:  2019        PMID: 31358479     DOI: 10.1016/j.prp.2019.152563

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?

Authors:  Tadaaki Inano; Hajime Yasuda; Yutaka Tsukune; Miyuki Tsutsui; Nadila Wali; Harumi Saeki; Kazunori Kajino; Okio Hino; Yasufumi Masaki; Norio Komatsu
Journal:  Case Rep Oncol       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.